About Us
Precise and Intelligent Biosignal Processing Solutions Provider
Nemesis is a leading provider of precise, customizable, and intelligent biosignal processing semiconductor solutions. Many biosensor and electrochemical sensor companies often face challenges in finding the suitable semiconductor chips for their products. This is primarily due to the groundbreaking nature of their products, which require a comprehensive understanding of both biotechnology and semiconductor processing expertise to bridge the gap between biochemical solutions and semiconductor processing. One of the major issues faced by users is the limited battery life and larger-than-expected product size, resulting in less accurate sensing of desired analytes and health signal information. For sensor experts, selecting the right chips can be quite overwhelming. At Nemesis, we understand the complexities involved in this process. Our team of experts is dedicated to providing innovative solutions that not only address these challenges but also improve the overall functionality and performance of bio-sensor and electrochemical sensor products. With our extensive knowledge and experience, we strive to empower companies in making informed decisions and advancing the field of biosignal processing.
Company History
Nemesis was founded in 2017 in response to the increasing demand for miniaturized healthcare devices and biosensors.
Received Government Research Fund
Other Projects Ongoing
Raised +5 mil Investment
Received 1.5 mil Private Research Fund
Sold Biosensor Unit
2019
Biosensor Chip Launched
2017
Founded Nemesis for Biosensors
2022
2023
2003
Achieved +30 mil sales only from RadioPulse
Sold RadioPulse to a Nasdaq Listed Company
Manufactured Wireless One-chip SoC and received Presidential Award
Founded RadioPulse
2006